已发表论文

Dupilumab 成功治疗银屑病合并大疱性类天疱疮:一病例报告

 

Authors Liu JH, Gao Q , Ma WY , Cheng ZL, Luo NN , Hao PS 

Received 30 March 2023

Accepted for publication 31 May 2023

Published 20 June 2023 Volume 2023:16 Pages 1583—1587

DOI https://doi.org/10.2147/CCID.S415019

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Jeffrey Weinberg

Abstract: Psoriasis is an immune-mediated chronic inflammatory disease that can be combined with complications such as diabetes, cardiovascular disease, obesity, and kidney disease. The comorbidity of psoriasis with autoimmune bullous diseases (AIBD) has been reported previously in several cases, the most frequent of which is bullous pemphigoid (BP). The underlying mechanisms of psoriasis with BP are not clear and there are no uniform treatment criteria. Based on previous case reports, the coexistence of psoriasis and BP may be related to inflammatory activity, medications, phototherapy, and infection. We report a case of a psoriasis patient who developed BP after taking Chinese herbal compounds and was successfully treated with dupilumab, which is the first reported case of applying dupilumab to treat psoriasis with BP comorbidities.
Keywords: autoimmune bullous diseases, dupilumab, biologics, comorbidity, Chinese herbal compounds